Statistical Yearbook 2016
D. 5. Medicaments
Methodology
On the permanent address of the beneficiary of the prescription
5.1. Summary data of the subsidized turnover of pharmacies, 2016
5.2. Main data of the subsidized turnover of pharmacies by legal title, 2016
5.2.1. Development of the subsidized turnover of pharmacies within the subsidisation category linked to enchanced indication by sex and age group, 2016
5.2.2. Development of the subsidized turnover of pharmacies within the subsidisation category linked to lifted indication by sex and age group, 2016
5.2.3. Main data of the subsidized turnover within the normative subsidisation category, 2016
5.2.3.1. Development of the turnover subsidized up to 85% by sex and age group, 2016
5.2.3.2. Development of the turnover subsidized up to 55% by sex and age group, 2016
5.2.3.3. Development of the turnover subsidized up to 50% by sex and age group, 2016
5.2.3.4. Development of the turnover subsidized up to 25% by sex and age group, 2016
5.2.3.5. Development of the turnover subsidized by fix amount by sex and age group, 2016
5.2.3.6. Development of the normative public health care by sex and age group, 2016
5.2.3.7. Development ot the subsidized turnover of combination preparations by sex and age group, 2016
5.3. Summary data of public health care (enchanced+lifted+normative) from subsidised turnover, 2016
On the basis of headquarters of the pharmacy redeeming the prescription
5.1. Summary data of the subsidized turnover of pharmacies, 2016
5.2. Main data of the subsidized turnover of pharmacies by legal title, 2016
5.2.1. Development of the subsidized turnover of pharmacies within the subsidisation category linked to enchanced indication by sex and age group, 2016
5.2.2. Development of the subsidized turnover of pharmacies within the subsidisation category linked to lifted indication by sex and age group, 2016
5.2.3. Main data of the subsidized turnover within the normative subsidisation category, 2016
5.2.3.1. Development of the turnover subsidized up to 85% by sex and age group, 2016
5.2.3.2. Development of the turnover subsidized up to 55% by sex and age group, 2016
5.2.3.3. Development of the turnover subsidized up to 50% by sex and age group, 2016
5.2.3.4. Development of the turnover subsidized up to 25% by sex and age group, 2016
5.2.3.5. Development of the turnover subsidized by fix amount by sex and age group, 2016
5.2.3.6. Development of the normative public health care by sex and age group, 2016
5.2.3.7. Development ot the subsidized turnover of combination preparations by sex and age group, 2016
5.3. Summary data of public health care (enchanced+lifted+normative) from subsidised turnover, 2016
NIHIFM --- Health, care
Department of Health Insurance Fund Operational Supervisory and Data Management / Statistical and Analysis Division, November 2017
NIHIFM --- Health, care